Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome |
|
https://doi.org/10.18632/oncotarget.25612
Roberta Fenoglio,
Savino Sciascia,
Giulietta Beltrame,
Paola Mesiano,
Michela Ferro,
Giacomo Quattrocchio,
Elisa Menegatti,
and Dario Roccatello
|
| 28799-28804 |
Exhaled breath analysis for gastric cancer diagnosis in Colombian patients
Exhaled breath analysis for gastric cancer diagnosis in Colombian patients |
|
https://doi.org/10.18632/oncotarget.25331
Cristhian Manuel Durán-Acevedo,
Aylen Lisset Jaimes-Mogollón,
Oscar Eduardo Gualdrón-Guerrero,
Tesfalem Geremariam Welearegay,
Julián Davíd Martinez-Marín,
Juan Martín Caceres-Tarazona,
Zayda Constanza Sánchez-Acevedo,
Kelvin de Jesus Beleño-Saenz,
Umut Cindemir,
Lars Österlund,
and Radu Ionescu
|
| 28805-28817 |
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) |
|
https://doi.org/10.18632/oncotarget.25522
Connie H.M. Ho,
Chi-Leung Chiang,
Francis A.S. Lee,
Horace C.W. Choi,
Jeffery C.H. Chan,
Cynthia S.Y. Yeung,
J.J. Huang,
Mark K.H. Chan,
Oliver Blanck,
and Frank C.S. Wong
|
| 28818-28829 |
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level |
|
https://doi.org/10.18632/oncotarget.25533
Antonella Rigo,
Isacco Ferrarini,
Giulio Innamorati,
and Fabrizio Vinante
|
| 28830-28841 |
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors |
|
https://doi.org/10.18632/oncotarget.25571
Ishwaria M. Subbiah,
Chad Tang,
Arvind Rao,
Gerald S. Falchook,
Vivek Subbiah,
Apostolia M. Tsimberidou,
Daniel Karp,
Razelle Kurzrock,
and David S. Hong
|
| 28842-28848 |
Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p
Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p |
|
https://doi.org/10.18632/oncotarget.25599
Tetsuya Idichi,
Naohiko Seki,
Hiroshi Kurahara,
Haruhi Fukuhisa,
Hiroko Toda,
Masataka Shimonosono,
Yasutaka Yamada,
Takayuki Arai,
Yoshiaki Kita,
Yuko Kijima,
Yuko Mataki,
Kosei Maemura,
and Shoji Natsugoe
|
| 28849-28865 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes |
|
https://doi.org/10.18632/oncotarget.25601
Elsa Maitre,
Philippe Bertrand,
Catherine Maingonnat,
Pierre-Julien Viailly,
Margaux Wiber,
Dina Naguib,
Véronique Salaün,
Edouard Cornet,
Gandhi Damaj,
Brigitte Sola,
Fabrice Jardin,
and Xavier Troussard
|
| 28866-28876 |
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma |
|
https://doi.org/10.18632/oncotarget.25608
Janine Hensel,
Antoinette Wetterwald,
Ramzi Temanni,
Irene Keller,
Carsten Riether,
Gabri van der Pluijm,
Marco G. Cecchini,
and George N. Thalmann
|
| 28877-28896 |
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis |
|
https://doi.org/10.18632/oncotarget.25622
Dai Chihara,
Nathan H. Fowler,
Yasuhiro Oki,
Michelle A. Fanale,
Loretta J. Nastoupil,
Jason R. Westin,
Luis E. Fayad,
Sattva S. Neelapu,
and Chan Yoon Cheah
|
| 28897-28902 |
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients |
|
https://doi.org/10.18632/oncotarget.25627
Michael Constantin Kirchberger,
Alvaro Moreira,
Michael Erdmann,
Gerold Schuler,
and Lucie Heinzerling
|
| 28903-28909 |
Marek’s disease virus oncoprotein Meq physically interacts with the chicken infectious anemia virus-encoded apoptotic protein apoptin
Marek’s disease virus oncoprotein Meq physically interacts with the chicken infectious anemia virus-encoded apoptotic protein apoptin |
|
https://doi.org/10.18632/oncotarget.25628
Andrew C. Brown,
Vishwanatha R.A.P. Reddy,
Joshua Lee,
and Venugopal Nair
|
| 28910-28920 |
V-ATPase-dependent repression of androgen receptor in prostate cancer cells
V-ATPase-dependent repression of androgen receptor in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25641
Yamhilette Licon-Munoz,
Colleen A. Fordyce,
Summer Raines Hayek,
and Karlett J. Parra
|
| 28921-28934 |
Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts
Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts |
|
https://doi.org/10.18632/oncotarget.25649
Yukie Yoshii,
Mitsuyoshi Yoshimoto,
Hiroki Matsumoto,
Hideaki Tashima,
Yuma Iwao,
Hiroyuki Takuwa,
Eiji Yoshida,
Hidekatsu Wakizaka,
Taiga Yamaya,
Ming-Rong Zhang,
Aya Sugyo,
Sayaka Hanadate,
Atsushi B. Tsuji,
and Tatsuya Higashi
|
| 28935-28950 |
MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma
MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25652
Cory Pettit,
Amy Webb,
Steve Walston,
Moumita Chatterjee,
Wei Chen,
Wendy Frankel,
Carlo Croce,
and Terence M. Williams
|
| 28951-28964 |
EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication
EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication |
|
https://doi.org/10.18632/oncotarget.25656
Sami Sebastian Khaznadar,
Martin Khan,
Elke Schmid,
Sebastian Gebhart,
Eva-Tessina Becker,
Thomas Krahn,
and Oliver von Ahsen
|
| 28965-28975 |
Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines
Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines |
|
https://doi.org/10.18632/oncotarget.25665
Mira Y. Gökyildirim,
Ulrich Grandel,
Katja Hattar,
Gabriele Dahlem,
Elena Schuetz,
Florian H. Leinberger,
Fabian Eberle,
Ulf Sibelius,
Friedrich Grimminger,
Werner Seeger,
Rita Engenhart-Cabillic,
Ekkehard Dikomey,
and Florentine S.B. Subtil
|
| 28976-28988 |
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target |
|
https://doi.org/10.18632/oncotarget.25615
David M. Goldenberg,
Rhona Stein,
and Robert M. Sharkey
|
| 28989-29006 |
Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment
Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment |
|
https://doi.org/10.18632/oncotarget.25626
David L. Elion,
and Rebecca S. Cook
|
| 29007-29017 |
Correction: Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies
Correction: Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies |
|
https://doi.org/10.18632/oncotarget.25715
Shaojin Zhang,
Qingwei Wang,
and Juanjuan He
|
| 29018-29018 |
